Pan-hypoileism: an endocrine disease.
- 1Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Abstract
Over the past four decades, the gastrointestinal tract has been increasingly recognized as a major endocrine organ. Each of its segments plays a distinct role in digestion, absorption, inter-organ signaling, and metabolic regulation, and each category of food requires a specific physiological response. Consequently, carnivores, herbivores, and omnivores have adapted their digestive systems to meet the demands of their typical diets. Signals arising from the digestive tract influence nearly all other organs and their metabolic activities. Gluconeogenesis, insulin resistance, energy expenditure, the hunger-satiety cycle, glucose effectiveness, lipid clearance, and gastric emptying are examples of metabolic processes profoundly regulated by the gut. Emerging evidence now suggests that the distal part of the human small intestine, the ileum, is progressively failing to perform its full range of functions, including its endocrine roles, in a substantial proportion of the population. This phenomenon may constitute a growing pandemic. The term pan-hypoileism has not previously been used. In this review, we explore why this term deserves recognition as an endocrine disease. Clarifying this condition may be important for both patients and physicians.
Related
- Craniopharyngioma Across the Lifespan: A Large Single-Center Cohort Study of Surgical Outcomes, Endocrine Morbidity, and Long-Term Disease Control
- Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditions
- Pituitary Apoplexy Presenting as a Transient Ischemic Attack: An Endocrine Emergency
- Familial lichen amyloidosis as a presenting sign of multiple endocrine neoplasia type 2A tumor syndrome.
- Research Progress on Genotoxicity and Molecular Mechanisms of Environmental Endocrine Disruptors
BibTeX
@article{santoro2026panhypoileism,
title = {{Pan-hypoileism: an endocrine disease.}},
author = {Sérgio Santoro},
journal = {Einstein (Sao Paulo, Brazil)},
year = {2026},
month = oct,
doi = {10.31744/einstein_journal/2026rw2548},
url = {https://europepmc.org/article/MED/42848641},
note = {CC BY},
}
RIS
TY - JOUR
TI - Pan-hypoileism: an endocrine disease.
AU - Sérgio Santoro
PY - 2026
DA - 2026/10/05
JO - Einstein (Sao Paulo, Brazil)
DO - 10.31744/einstein_journal/2026rw2548
UR - https://europepmc.org/article/MED/42848641
AB - Over the past four decades, the gastrointestinal tract has been increasingly recognized as a major endocrine organ. Each of its segments plays a distinct role in digestion, absorption, inter-organ signaling, and metabolic regulation, and each category of food requires a specific physiological response. Consequently, carnivores, herbivores, and omnivores have adapted their digestive systems to meet the demands of their typical diets. Signals arising from the digestive tract influence nearly all other organs and their metabolic activities. Gluconeogenesis, insulin resistance, energy expenditure, the hunger-satiety cycle, glucose effectiveness, lipid clearance, and gastric emptying are examples of metabolic processes profoundly regulated by the gut. Emerging evidence now suggests that the distal part of the human small intestine, the ileum, is progressively failing to perform its full range of functions, including its endocrine roles, in a substantial proportion of the population. This phenomenon may constitute a growing pandemic. The term pan-hypoileism has not previously been used. In this review, we explore why this term deserves recognition as an endocrine disease. Clarifying this condition may be important for both patients and physicians.
SN - 1679-4508
SN - 2317-6385
ER -